NKGen Biotech Inc - NKGN Net Assets per Single Share

NKGen Biotech, Inc. (NKGN) is implementing AI bioreactors to automate the production of cell therapies, thereby reducing personnel costs. Book value per share data visualizes equity dynamics, while the -2.70 level captures the latest values. Patents for Alzheimer's disease therapy create potential, but a lack of funding is hindering research, and pressure from market behemoths is complicating expansion.

NKGen Biotech Inc (NKGN) Equity per Share: for the period 02/21/2024 - 03/15/2025

nkgenbiotech.com - analytical breakdowns and key metrics (NKGN)

- price and consensus price forecast:
Stock Price NKGen|NKGN - Analyst Target Range
- market capitalization data:
Market Value NKGen Biotech, Inc.|NKGN - Business Value
- book capitalization data:
Net Assets per Single Share NKGen Biotech|NKGN - Accounting Capitalization|Market Capitalization to Book Value Ratio nkgenbiotech.com|NKGN - Company Assets
- debt and liquidity data:
Total Debt to Equity Ratio NKGen Biotech, Inc.|NKGN - Long-Term Debt to Capital|Short-Term Debt to Equity NKGen Biotech|NKGN - Aggregate Debt Obligations|Debt to Book Capitalization Ratio NKGen Biotech, Inc.
Fundamental company valuation:NKGen, NKGN

Investors are assessing the potential of NKGen Biotech, Inc. (NKGN) through the lens of intellectual property capitalization and the costs of clinical trials for Alzheimer's disease. The current book value per share, equal to -2.70, reflects the net asset value per security, determining the actual tangible protection of investments in this high-risk biotech sector when analyzing the price action on the chart.

Competitor analysis for NKGen Biotech, Inc.

Book Value per Share BIIB|NBIX: Book Value of One Share|Net Assets per Single Share Regencell Bioscience|AXSM (axsome.com) - Equity per Share|Net Assets per Single Share ACADIA Pharmaceuticals Inc. (ACAD)|Equity per Share Xenon Pharmaceuticals Inc.|Viking Pharma - Book Value per Share|Net Asset Value per Share Supernus Corp SUPN|Accounting Value per Share CPRX (Catalyst Pharmaceuticals)|denalitherapeutics.com - Book Value per Share|Net Assets per Single Share Harmony Biosciences Holdings, Inc. (HRMY)|BHVN: Accounting Value of a Share|Net Assets per Single Share AMLX|TRVI (Trevi Corp) - Net Asset Value per Share|Net Assets per Single Share Praxis Precision Medicines (PRAX)|Equity per Share AVXL|Net Assets per Single Share CBLL|Book Value per Share Prothena Corporation (PRTA)|ALEC (Alector) - Book Value per Share|Book Value of One Share Annexon Biosciences Inc. ANNX|OMER (Omeros Corp.) - Book Value per Share|NGNE: Net Asset Value per Share|Net Assets per Single Share AC Immune SA|Equity per Share Voyager Therapeutics Inc|NMRA - Accounting Value per Share|Accounting Value of a Share Scilex Holding Company, Inc.|Book Value per Share Tevogen Bio Holdings (TVGN)|Net Assets per Single Share alphacognition.com (ACOG)|Book Value per Share CGTX|Inhibikase Therapeutics Inc - Net Assets per Share|SAVA (Cassava) - Net Assets per Single Share|Assertio Holdings, Inc. (ASRT) - Net Asset Value per Share|COYA - Accounting Value per Share|Vistagen (VTGN) - Book Price of a Share|Book Value per Share OVID (Ovid Therapeutics Inc)|Net Asset Value per Share Acumen Pharmaceuticals Inc.|Book Value per Share CRVO (CervoMed Inc)|Accounting Value per Share alteritytherapeutics.com (ATHE)|Book Value per Share Clene|PEPG - Accounting Value of a Share|Accounting Value per Share Jupiter Neurosciences Inc (JUNS)|RLMD - Accounting Value of a Share|Annovis Bio Corp - Book Value per Share|GRCE (Grace Therapeutics) - Net Assets per Share|Net Assets per Single Share Firefly Neuroscience, Inc (AIFF)|Equity per Share ANEW Medical, Inc.|Book Value per Share NRSN (NeuroSense Therapeutics)|Accounting Value per Share Reviva Pharmaceuticals Holdings Inc. RVPH|Accounting Value per Share MTVA|NeurAxis Inc - Net Assets per Share|Helius Medical Technologies Inc. (HSDT) - Net Assets per Single Share|PASG: Equity per Share|NEUP: Net Assets per Single Share|Minerva Neurosciences Inc (NERV) - Book Value per Share|Athira - Book Value per Share|Book Value of One Share ADXN|Net Assets per Single Share Alzamend Neuro, Inc. ALZN|Equity per Share CYCN (cyclerion.com)|PTIX - Net Assets per Single Share|Equity per Share Pasithea Therapeutics Corp KTTA|CRGT (Cortigent Medical) - Book Value per Share|Avenue Therapeutics Inc (ATXI) - Net Asset Value per Share|BCLI: Accounting Value per Share|CARA (caratherapeutics.com) - Book Value per Share|CHRO - Net Assets per Single Share|Accounting Value of a Share ELYM|Intra-Cellular Therapies - Net Assets per Single Share|Net Asset Value per Share LBPH (Longboard)|MRNS - Net Assets per Single Share|neurobopharma.com - Equity per Share|Sage Therapeutics - Net Assets per Single Share|SNPX - Book Value per Share|Book Value per Share TRVN (Trevena, Inc)|Vigil Neuroscience, Inc. (VIGL) - Book Value of One Share|Book Value per Share WENA (Anew Medical)|Net Asset Value per Share CERE